Advanced Enzyme Technologies
ADVENZYMES · Pharma > Pharmaceuticals & Drugs · Chairman: Vasant Rathi Listing date: Aug. 2, 2016 · Employees: 750 · Thane · http://www.advancedenzymes.com

Stock Price vs Company Growth
1d
1.8%
1w
1.2%
1m
1.8%
3m
9.4%
6m
1.9%
1y
16.5%
5y
1.4%
all
3.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 308 1.8%
299
356
Company Overview

Sales
707 Cr
Growth: 9.7%
Profit after Tax
147 Cr
Growth: 7.7%
Small Cap
3,450 Cr
P/E: 23.4x
Industry P/E: 33.3x
Fundamentals

Sales (Cr) ₹ 707
Growth 9.7%
EBITDA 30.8%
P/S 4.9x
Dividend 1.3%
P/E 23.4x
Book Value ₹ 134
PEG Ratio 2.4x
ROE 10.1%
P/B 2.3x
Shareholding Pattern

Institutions
Orbimed Asia Iii Mauritius Limited
9.89 %
Nalanda India Equity Fund Limited
4.74 %
Hdfc Small Cap Fund
4.39 %
Orbimed Asia Iii Mauritius Fvci Limited
2.2 %
Icici Prudential Esg Fund
2.14 %
Promoters
Vasant Rathi
32.72 %
Advanced Vital Enzymes Private Limited
8.91 %
Reshma Namita Rathi
2.37 %
Rasika Vasant Rathi
2.36 %
Rachana Vasant Rathi
2.36 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost-effective unique and innovative solutions, thereby enabling their customers to develop superior products and processes.
Investors (87)
Followers (13)